Redsense Medical

OTCQX is a trading platform in the United States operated by the OTC Markets Group for securities not listed on a national stock exchange. The purpose of a cross-trading on OTCQX is to satisfy an increasing interest from US investors and to increase accessibility to the US capital market. Upon possible approval, Redsense Medical shares will be traded with a US ticker symbol and a share price in USD, in US market hours.

"Given that Redsense Medical has most of its revenue in the US, it is also natural that we initiate a process to facilitate for North American investors to trade in the Redsense Medical share. In addition, through a cross-trade on OTCQX, we make it easier for international investors and institutions who are considering having exposure to our shares. This initiative is in line with our increased focus on the US market in general and with a dual-quotation we will meet an increased interest in Redsense Medical", says Pontus Nobréus, CEO of Redsense Medical AB.